ERC-Proof-of-Concept-Grant for Paolo Arosio
Paolo Arosio, professor at the Institute for Chemical and Bioengineering, receives an ERC Proof of Concept grant to develop a technology for?the rapid, specific, and scalable isolation of vesicles and molecules from biofluids with applications in diagnostics and disease monitoring as well as drug manufacturing.
Important healthcare applications require isolating tailored biomolecules and vesicles from complex biofluids. Examples include tests for monitoring pathologies and the manufacturing of life-saving biological drugs. This process faces challenges due to the significant levels of impurities that can contaminate the target species.
Paolo Arosio is a professor of Biochemical Engineering. In this ERC Proof of Concept, he and his team will develop a polymeric coacervate-based technology for the rapid, specific, and scalable isolation of vesicles and molecules from biofluids. This technology could be applied in clinical settings for diagnostics and disease monitoring, as well as in the biopharmaceutical industry to enhance the quality and safety of biological nanocarriers for gene and RNA-based therapies.
Enabling transfer to society
ERC Proof of Concept (PoC) Grants provide top-up funding to researchers who wish to explore the societal or commercial potential of their results. Worth 150,000 EUR each, they are part of the EU's research and innovation programme, Horizon 2020.
Paolo Arosio also holds a Consolidator Grant of the European Research Council from 2021 to 2026.
Further information
Arosio groupAlways up to date
Would you like to always receive the most important internal information and news from ETH Zurich? Then subscribe to the "internal news" newsletter and visit Staffnet, the information portal for ETH employees.